Compare GUT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GUT | YDES |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.5M | 543.0M |
| IPO Year | N/A | N/A |
| Metric | GUT | YDES |
|---|---|---|
| Price | $6.59 | $2.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 249.0K | 35.0K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.42 | $2.14 |
| 52 Week High | $6.70 | $25.00 |
| Indicator | GUT | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 65.15 | 31.96 |
| Support Level | $6.09 | $2.14 |
| Resistance Level | $6.70 | $5.36 |
| Average True Range (ATR) | 0.09 | 0.43 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 69.77 | 10.61 |
Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.